Abstract: Devices and techniques are generally described for three dimensional room modeling. In various examples, 3D mesh data representing a room may be received. Plane data comprising a plurality of planes may be received. Each plane of the plurality of planes may represent a planar surface detected in the room. In some cases, a first plurality of wall candidates for a 3D model of the room may be determined based at least in part on the plane data. A second plurality of wall candidates for the 3D model of the room may be determined by modifying the first plurality of wall candidates based on a comparison of the first plurality of wall candidates to the 3D mesh data. The 3D model of the room may be generated based at least in part on the second plurality of wall candidates.

Abstract: Techniques for placing and manipulating multiple three-dimensional (3D) models using mobile augmented reality (AR) are described. One technique includes receiving a first request to initialize an AR simulation of a first product for sale within a physical environment. In response to the first request, a first 3D model of the first product for sale is rendered onto the screen. After rendering the first 3D model, a second request to visualize a second product for sale within the physical environment is received during the AR simulation of the first product for sale. In response to the second request, a second 3D model of the second product for sale is rendered onto the screen with the first 3D model.

Abstract: A process can be used for producing a distillate product with a methanol concentration greater than the concentration of methanol in the minimum boiling azeotrope of methanol and methyl (meth)acrylate, from a mixture with a methanol concentration less than the concentration of methanol in the minimum boiling azeotrope of methanol and methyl (meth)acrylate, in a distillation column. A transesterification process for preparing C6- to C22-alkyl, aryl or alkenyl (meth)acrylates from methyl (meth)acrylate is also provided.

Abstract: A device for treating tissue includes a capsule extending longitudinally from a proximal end to a distal end and including a channel extending therethrough, the capsule releasably coupled to a proximal portion of the device and clip jaws, proximal ends of which are slidably received within the channel of the capsule so that the clip jaws are movable between an open configuration and a closed configuration. Clip jaws are configured so that a distance between the distal ends of the clip jaws in an open configuration is between 15 and 18 millimeters. Clip jaws further include barbs extending from a distal portion thereof.

Abstract: Devices and techniques are generally described for three dimensional room modeling. In various examples, 3D mesh data representing a room may be received. Plane data comprising a plurality of planes may be received. Each plane of the plurality of planes may represent a planar surface detected in the room. In some cases, a first plurality of wall candidates for a 3D model of the room may be determined based at least in part on the plane data. A second plurality of wall candidates for the 3D model of the room may be determined by modifying the first plurality of wall candidates based on a comparison of the first plurality of wall candidates to the 3D mesh data. The 3D model of the room may be generated based at least in part on the second plurality of wall candidates.

Abstract: Techniques for placing and manipulating multiple three-dimensional (3D) models using mobile augmented reality (AR) are described. One technique includes receiving a first request to initialize an AR simulation of a first product for sale within a physical environment. In response to the first request, a first 3D model of the first product for sale is rendered onto the screen. After rendering the first 3D model, a second request to visualize a second product for sale within the physical environment is received during the AR simulation of the first product for sale. In response to the second request, a second 3D model of the second product for sale is rendered onto the screen with the first 3D model.

Abstract: Techniques for placing and manipulating multiple three-dimensional (3D) models using mobile augmented reality (AR) are described. One technique includes receiving a first request to initialize an AR simulation of a first product for sale within a physical environment. In response to the first request, a first 3D model of the first product for sale is rendered onto the screen. After rendering the first 3D model, a second request to visualize a second product for sale within the physical environment is received during the AR simulation of the first product for sale. In response to the second request, a second 3D model of the second product for sale is rendered onto the screen with the first 3D model.

Abstract: A virtual vertical surface in a three-dimensional space that represents a physical room may be detected. Responsive to a first user input gesture, movement of a virtual object within the three-dimensional space may be displayed. The movement may be to a first location in which a portion of the virtual object intersects a portion of the virtual vertical surface. A virtual vertical surface designator may be displayed corresponding to the virtual vertical surface based at least in part on the portion of the virtual object intersecting the portion of the virtual vertical surface. Upon determining that a second user input gesture meets or exceeds a movement threshold, movement of the three-dimensional object from the first location to a second location within the three-dimensional space may be displayed. The second location may appear beyond the virtual vertical surface.

Abstract: Systems and methods for displaying digital objects in multiple configurations based on a placement location within an Augmented Reality (AR) display. The systems are enabled to receive image data, identify multiple horizontal surfaces within the image data, and place a digital object model within the image data. The digital object model is placed in the AR display in a first configuration when placed with an anchor of the digital object model on a first horizontal surface and in a second configuration when placed with the anchor on a second horizontal surface.

Abstract: The oxygen evolution reaction (OER)-catalyzing activity of transition metal perovskite oxide catalysts depends on the occupancy of the ?-bonding orbital of eg symmetry parentage of the active cation. Catalysts having preferred values of eg orbital filling can have a high intrinsic activity for catalysis of the OER.

Abstract: Formulations for topical or local administration of drugs directly to the breast or chest to produce a regional or local effect with lower systemic drug levels than when an effective amount is administered systemically are disclosed herein. In a preferred embodiment, the drug is administered to the surface of the breast, areola, or directly to the nipple. The formulations provide increased patient comfort, increased bioavailability and relatively high blood levels in the region to be treated with a reduction of side effects compared to those administered systemically. The preferred formulations contain drugs in the form of micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or carrier. The excipient or carrier may modify the release rates or enhance absorption into the affected area. The drug formulation may be in the form of a cream, lotion or foam.

Abstract: The oxygen evolution reaction (OER)-catalyzing activity of transition metal perovskite oxide catalysts depends on the occupancy of the ?-bonding orbital of eg symmetry parentage of the active cation. Catalysts having preferred values of eg orbital filling can have a high intrinsic activity for catalysis of the OER.

Abstract: A wrap for a microwavable container, such as a cup with a removable lid, the wrap having a separable hinged portion to allow the lid of the container to be removed. The separable portion can then be returned to its original position, and the wrap and enclosed container heated in a microwave oven. During heating, the wrap remains relatively cool to the touch, so that the wrap and container can be removed from the oven by grasping the wrap, without contacting the hot exterior of the container.

Abstract: Formulations for topical or local administration of drugs directly to the breast or chest to produce a regional or local effect with lower systemic drug levels than when an effective amount is administered systemically are disclosed herein. In a preferred embodiment, the drug is administered to the surface of the breast, areola, or directly to the nipple. The formulations provide increased patient comfort, increased bioavailability and relatively high blood levels in the region to be treated with a reduction of side effects compared to those administered systemically. The preferred formulations contain drugs in the form of micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or carrier. The excipient or carrier may modify the release rates or enhance absorption into the affected area. The drug formulation may be in the form of a cream, lotion or foam.

Abstract: Drug delivery compositions which are suitable for transvaginal administration for the treatment of diseases and disorders of the urogenital tract are described. The drug delivery compositions are administered directly to the vagina using a convenient transvaginal application that deposits a very small volume of drug at the desired site for delivery. This method of administration reduces the systemic levels of the drugs and decreases the side effects which are associated with systemic administration. In the preferred embodiment, the compositions are in the form of a gel. The formulation is administered in volumes of less than or equal to 1 milliliter. In the preferred embodiment, the composition contains an antimuscarinc drug, such as oxybutynin.

Abstract: Formulations for topical or local administration of drugs directly to the breast or chest to produce a regional or local effect with lower systemic drug levels than when an effective amount is administered systemically are disclosed herein. In a preferred embodiment, the drug is administered to the surface of the breast, areola, or directly to the nipple. The formulations provide increased patient comfort, increased bioavailability and relatively high blood levels in the region to be treated with a reduction of side effects compared to those administered systemically. The preferred formulations contain drugs in the form of micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or carrier. The excipient or carrier may modify the release rates or enhance absorption into the affected area. The drug formulation may be in the form of a cream, lotion or foam.

Abstract: An airless application system. The system includes a primary product container, a secondary product container, and a sprayer in fluid communication with the primary product container and the secondary product container.

Abstract: A wrap-around article carrier has a plurality of tuck-in flaps and gussets to restrain the articles the carrier is designed to carry from falling out of the carrier. The carrier further comprises a dispensing feature, which once removed allows the articles in the carrier to be dispensed in a controlled manner.

Abstract: A wrap for a microwavable container, such as a cup with a removable lid, the wrap having a separable hinged portion to allow the lid of the container to be removed. The separable portion can then be returned to its original position, and the wrap and enclosed container heated in a microwave oven. During heating, the wrap remains relatively cool to the touch, so that the wrap and container can be removed from the oven by grasping the wrap, without contacting the hot exterior of the container.

Abstract: A new type of secondary locking system for article carriers consisting of at least one secondary male lock with two shoulders that is attached by a neck to the edge of a outer flap on the carrier for use with a primary locking system. An inner flap has a secondary female opening for each secondary male lock. The secondary female opening is formed by a secondary cut line and fold line with the center of the fold line projecting towards the edge of the flap while of the center of the secondary cut line projects away from the edge of the flap to guide the secondary male lock into a flat position against the inside of the inner flap. The shoulders on the secondary male lock are engaged against locking ledges along the extensions of the secondary cut line. A pair of slits may be formed at the end of the fold lines that project inwardly to allow the secondary male lock to slide into a flat position.